ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO862

Peripheral Vascular Calcification Score Is Better Than Abdominal Aortic Calcification Score of Plain Radiographs in Predicting Cardiovascular Mortality in Hemodialysis Patients

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Mo, Min, Shunde Hospital Southern Medical University, Foshan, China
  • Pan, Jianyi, Shunde Hospital Southern Medical University, Foshan, China
  • Zhang, Wei, Shunde Hospital Southern Medical University, Foshan, China
  • Zheng, Qingkun, Shunde Hospital Southern Medical University, Foshan, China
  • Chen, Jinzhong, Shunde Hospital Southern Medical University, Foshan, China
  • Dou, Xianrui, Shunde Hospital Southern Medical University, Foshan, China
Background

Cardiovascular disease (CVD) is the major cause of death for dialysis patients. Vascular calcification (VC) serves as a key pathological factor resulting in the CVD. KDIGO advocates abdominal aortic calcification score (AACS) to evaluate VC. Meanwhile, some studies showed that the peripheral vascular calcification score (PVCS) could predict cardiovascular mortality. However, no studies compare two VC score systems in clinic. Thus, this study compared two VC score systems in predicting mortality of HD patients.

Methods

In this retrospective study with 243 HD patients, AACS and PVCS were measured from plain radiograph of lateral abdominal radiograph and pelvis and both hands radiographs, respectively.

Results

The prevalence of VC was 68.5% (167 patients), most patients showed AAC (63.7%). During the follow-up period of 24 (13,44) months, 65(26.6%) patients died. Among these died patients, 35 (53.8%) patients died of cardiovascular disease. The patients died showed higher AACS (5.0 (1.25,14.0) vs. 2.0 (0,6.75), P=0.001), PVCS (2.0(0,5) vs. 0(0,2.0),P=0.000), and overall VC score ( 5 (0,16) vs. 1 (0,6), P=0.001) compared to alive patients. When ROC curve was used to predict all-cause mortality, for PVCS, the area under ROC curve (AUROC) was 0.695 with 57.4% of specificity and 71.8% of sensitivity (P=0.000). As for AACS, the AUROC was 0.666 with 62.9% of specificity and 61.7% of sensitivity (P=0.001). The AUROC for PVCS was 0.668 with 68.0% of specificity and 62.5% of sensitivity (P=0.007), while the AUROC for AACS was 0.574 with 38.1% of specificity and 75.0% of sensitivity (P=0.239) when used to predict cardiovascular mortality. By the COX multivariate regression analysis (adjusted for age, gender, diabetes, period of dialysis, albumin, hypertension, cholesterol, phosphorus, calcium, intact-parathyroid and Kt/V), the PVCS was independently associated with all-cause mortality and cardiovascular mortality (HR, 1.287;95%CI, 1.140-1.453, and HR, 1.272;95%CI,1.079-1.499), respectively. However, AACS was only associated with all-cause mortality (HR, 1.069; 95%CI, 1.008-1.133) but not cardiovascular mortality.

Conclusion

VC score is independently associated with mortality. The PVCS is a better parameter in predicting cardiovascular mortality as compared with AACS.